首页> 外文期刊>Dermatology Online Journal >Inflamed actinic keratoses associated with pemetrexed and carboplatin therapy
【24h】

Inflamed actinic keratoses associated with pemetrexed and carboplatin therapy

机译:培美曲塞和卡铂治疗相关的发炎性光化性角化病

获取原文
           

摘要

Eruptive actinic keratosis (AK) consequent to systemic chemotherapy can be confused with drug allergies. We present the first case of inflamed AKs in one patient after receiving combination therapy with pemetrexed and carboplatin.A 68-year-old woman with non-small cell lung adenocarcinoma (NSCLC) presented with numerous pruritic ill-defined, gritty, erythematous papules consistent with AKs on her upper chest, upper back, and arms two weeks after completing the first cycle of combination therapy with carboplatin and pemetrexed. The care team managed her with topical steroids and the lesions resolved within one month. The patient resumed the second cycle of chemotherapy and reported the occurrence of a similar but milder eruption.This case illustrates that eruptive AKs should be considered in the differential diagnosis of drug-related rashes, especially if the physical exam is suggestive. The mainstay of treatment should be directed at symptomatic improvement, and chemotherapy may be continued.
机译:全身化疗导致的爆发性光化性角化病(AK)可与药物过敏相混淆。我们在一位患者中接受培美曲塞和卡铂联合治疗后出现了第一例AKs炎症.68岁的女性患有非小细胞性肺腺癌(NSCLC),表现为许多瘙痒性不明确,坚韧不拔,红斑丘疹一致在完成卡铂和培美曲塞联合治疗的第一个周期后两周,她的上胸部,上背部和手臂上都有AK。护理团队为她提供了局部类固醇治疗,并且病变在一个月内得到解决。该患者恢复了第二个化疗周期,并报告了类似但较轻的喷发。该病例说明,在鉴别与药物相关的皮疹时应考虑使用喷发性AK,尤其是在体格检查提示的情况下。治疗的主要对象应该是症状改善,并且可以继续化疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号